ARCHIVES

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

October 30, 1992

ACCC To Ask Congress To Earmark Appropriations For Construction Of Community Cancer Centers

January 17, 1975

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980

Diet/Nutrition Advisory Group Blast Fund Limit, Incurs Schmidt Wrath

February 4, 1977